Page 73 - Express Scripts News Today

The Massachusetts attorney general alleged that the pharmacy giant failed to follow state law intended to keep workers compensation costs low.

/PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced the appointment...

Drug-makers, pharmacies, and physicians blame pharmacy benefit managers for high drug prices. Florida has already taken action. Now, Congress is finally on board, too, but will it matter?

Massachusetts Attorney General Andrea Campbell said Monday she’s reached a $6.1 million settlement with CVS to resolve allegations the pharmacy failed to...

Massachusetts Attorney General Andrea Joy Campbell's office reports it has reached a $6.15 million settlement with CVS Pharmacy, Inc. to resolve

The FTC said the acquisition would allow Amgen to entrench Horizon’s monopoly on medications for thyroid eye disease and chronic refractory gout.

The $28 billion acquisition would allow Amgen to entrench Horizon’s monopoly on certain medications, the FTC argues.

CVS Health is ending the clinical trial business it started two years ago. "We continually evaluate our portfolio of assets to ensure they are aligned with our long-term strategic priorities," said Mike DeAngelis, executive director of CVS Corporate Communications, by statement. "As a result, we're winding down our Clinical Trial Services business in a phased way, with a full

Agency says a tie-up would stifle competition for the development of treatments for serious illnesses.

As part of the settlement, filed Monday, CVS agreed to work with the attorney general’s office to help prevent overcharges.